The diagnostic meaning of clinical-epidemiological signs among MDR TB patients Source: Eur Respir J 2006; 28: Suppl. 50, 378s Year: 2006
The depressive syndrome as a response to the TB treatment in MDR TB patients Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III Year: 2008
The clinical features and the risk factors of teenagers cases with MDR-TB in Romania Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010
Effectiveness of treatment for MDR TB in children and adolescents Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases Year: 2007
The clinical features and treatment results of cases with multidrug resistant pulmonary tuberculosis Source: Annual Congress 2004 - Problems of resistance and HIV coinfection in tuberculosis Year: 2004
Managing adult and children XDR-TB cases with limited clinical options Source: International Congress 2018 – CC4 Tuberculosis Year: 2018
The comparative analysis of treatment effectiveness in children and adolescents with MDR TB with anti-TB drugs of the first and second lines Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012
Surgical treatment for MDR TB patients – preliminary results from a Romanian MDR TB centre Source: Eur Respir J 2006; 28: Suppl. 50, 276s Year: 2006
The effectiveness of MDR TB treatment in children and adolescents depending on its duration Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012
The characteristics of previous tuberculosis treatment programmes in patients with tuberculosis relapses Source: Eur Respir J 2001; 18: Suppl. 33, 473s Year: 2001
Medico-social features of resistance development to new anti–TB drugs in patients with MDR/XDR TB Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021
Preventive chemotherapy effectiveness in children and adolescents, contacting TB patients with DR TB strains Source: Eur Respir J 2006; 28: Suppl. 50, 536s Year: 2006
HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015
Treatment outcomes among childhood extensively drug-resistant tuberculosis patients in Pakistan Source: ERJ Open Res, 8 (1) 00551-2021; 10.1183/23120541.00551-2021 Year: 2022
The clinical and radiological comparison of new, recurrent and multidrug resistant cases of pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 169s Year: 2002
Which is the level of education among TB and MDR TB patients about their disease? A patient‘s questionnaire Source: Eur Respir J 2006; 28: Suppl. 50, 588s Year: 2006
Differences in the clinical manifestation and diagnosis of TB in children and adults Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014
The experience of complex treatment of XDR-TB patients Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance Year: 2009
The peculiarities of histological diagnostic of tuberculosis (TB) in HIV-infected patients in Ukraine Source: Eur Respir J 2006; 28: Suppl. 50, 20s Year: 2006
Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015